Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.

Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J Infect Dis. 2010 Apr 01; 201(7):1045-53.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.